Express Scripts Holding (ESRX) - 12 Year Stock Split History

Historical stock splits for Express Scripts Holding since 2006. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Sector Industry Market Cap Revenue
Medical Medical Services $0.008B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.420B 24.90
PRA Health Sciences (PRAH) United States $6.370B 30.50
Charles River Laboratories (CRL) United States $5.747B 22.34
HealthEquity (HQY) United States $5.051B 107.11
INC Research Holdings (SYNH) United States $5.021B 22.10
Premier (PINC) United States $4.967B 20.09
Teladoc (TDOC) United States $4.257B 0.00
NovoCure (NVCR) Jersey $3.229B 0.00
AMN Healthcare Services Inc (AMN) United States $2.900B 22.12
Intrexon (XON) United States $1.893B 0.00
BioTelemetry (BEAT) United States $1.638B 45.41
Medpace Holdings (MEDP) United States $1.630B 25.93
IKang Healthcare (KANG) China $1.415B 78.35
Healthways (TVTY) United States $1.390B 19.69
Natera (NTRA) United States $1.239B 0.00
China Cord Blood (CO) China $0.966B 25.84
Apollo Medical Holdings (AMEH) United States $0.831B 0.00
Surgery Partners (SGRY) United States $0.741B 0.00
Civitas Solutions (CIVI) United States $0.587B 14.95
CareDx (CDNA) United States $0.443B 0.00
OncoCyte (OCX) United States $0.112B 0.00
Interpace Diagnostics (IDXG) United States $0.029B 0.00
Cancer Genetics (CGIX) United States $0.024B 0.00
Biocept (BIOC) United States $0.014B 0.00
OpGen (OPGN) United States $0.012B 0.00
FORM Holdings (XSPA) United States $0.008B 0.00